This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Airbus vs. Boeing: (A), (B), (C), (D), (E), and (F), Teaching Note
Casadesus-Masanell, Ramon; Voigt, Erich Alexander; Mitchell, JordanTeaching Note HBS-710405-EStrategyTeaching Note for [707447], [707448], [707449]. [707450], [707451], and [707452].Starting at €0.00
-
Competir mediante modelos de negocio (C): Interdependencia, interacción táctica e interacción estratégica
Casadesus-Masanell, Ramon; Ricart Costa, Joan EnricCase HBS-711S24StrategyStarting at €5.74
-
Betfair (B), (C), and (D) Case Slides
Casadesus-Masanell, Ramon; Heilbron, JohnCase HBS-717520-EStrategyContains slides related to the Betfair B, C, and D cases.Starting at €5.74
-
Betfair (C)
Casadesus-Masanell, Ramon; Heilbron, John; Campbell, NeilCase HBS-717518-EStrategyPrompted by a takeover bid from CVC, Betfair reassesses the strengths and weaknesses of the exchange model.Starting at €5.74
-
Imprimis (C)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCase HBS-717497-EEntrepreneurshipThis case is a supplement to Imprimis (Case A) and Imprimis (Case B). Set in 2015, it first describes Imprimis's decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the problem of high drug prices in the United States. Recent, drastic price hikes on pharmaceutical drugs, such as those initiated by Turing Pharmaceuticals under CEO ...Starting at €5.74
-
ATH Technologies (E)
Simons, Robert L.; Packard, JenniferCase HBS-117017-EStrategySupplements the (A) case. Designed as an in-class handout.Starting at €5.74
-
Merck: Managing Vioxx (E)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-109084-EStarting at €5.74
-
Launching Telmore (C)
Casadesus-Masanell, Ramon; Fernandez, Celso; Jobke, MoritzCase HBS-708416-EStrategySupplement to the (A) case. An abstract is not available for this product.Starting at €5.74
-
Merck: Managing Vioxx (C)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-109082-EStarting at €5.74
-
ATH Technologies (C)
Simons, Robert L.; Packard, JenniferCase HBS-117015-EStrategySupplements the (A) case. Designed as an in-class handout.Starting at €5.74